March « 2015 « Science and Enterprise

Pittsburgh Alliance Applies Big Data to Health Innovations

By Alan, on March 16th, 2015%

(Nemo/Pixabay)

16 March 2015. Three institutions in Pittsburgh, Pennsylvania — two universities and a medical center — are collaborating on innovations that make use of the rapidy growing pool of medical data, to develop new technologies that they say will change the way diseases are prevented, diagnosed, and treated. The alliance of Carnegie . . . → Read More: Pittsburgh Alliance Applies Big Data to Health Innovations

Device Shown to Reduce Stroke in Heart Valve Replacements

By Alan, on March 16th, 2015%

(NASA.gov)

16 March 2015. First results from a clinical trial in Europe and Israel show an experimental mesh device deployed during heart valve replacement surgery sharply reduces strokes and cognitive damage, complications associated with the procedure. A team from Yale University School of Medicine presented its findings yesterday of the study testing TriGuard, . . . → Read More: Device Shown to Reduce Stroke in Heart Valve Replacements

Making Bootstraps: A Mid-Career Break to Boost Wage Growth

By Alan, on March 15th, 2015%

(Stux/Pixabay)

Summary

15 March 2015. Finding a solution to stubborn wage stagnation in the U.S. has so far eluded policy makers, with most ideas aimed at lower-pay workers, such as raising the minimum wage. A remedy needs to be found for working people at all wage levels. One solution to consider is providing . . . → Read More: Making Bootstraps: A Mid-Career Break to Boost Wage Growth

Campaign Seeks More Minorities in Brain Disorder Trials

By Alan, on March 13th, 2015%

Today Show’s Al Roker, left, with B. Smith and Dan Gasby (Today.com)

13 March 2015. A new public service campaign led by former actress and restaurateur B. Smith aims to recruit more minorities in clinical trials for brain disorders, such Alzheimer’s disease, from which Smith suffers. Smith and her husband Dan Gasby are . . . → Read More: Campaign Seeks More Minorities in Brain Disorder Trials

Stem Cells Shown to Stop Decline for Some ALS Patients

By Alan, on March 13th, 2015%

Neuron in tissue culture (EnCor Biotechnology Inc./Wikimedia Commons)

13 March 2015. An intermediate-stage clinical trial of a stem cell therapy to treat amyotrophic lateral sclerosis, or ALS, shows some patients receiving the treatments nearly stopped the decline or improved their muscle functions. Neuralstem Inc., a biotechnology company in Germantown, Maryland sponsoring the study, . . . → Read More: Stem Cells Shown to Stop Decline for Some ALS Patients

Second-Hand E-Cigarette Emissions Pose Health Risks

By Alan, on March 12th, 2015%

(RTI International)

12 March 2015. Exhaled particles from electronic cigarette smokers contain nicotine and other chemicals that could pose health risks to non-smokers in the same room, according to new research. The study, by RTI International, a research institute in North Carolina, aims to provide more health information about the largely unregulated and . . . → Read More: Second-Hand E-Cigarette Emissions Pose Health Risks

Immunotherapy Biotech Raising $45 Million in IPO

By Alan, on March 12th, 2015%

Herpes simplex viruses (Centers for Disease Control and Prevention)

12 March 2015. Genocea Biosciences Inc., a biotechnology company developing immunotherapies to treat genital herpes and other diseases, is raising $45 million in its initial public offering of stock. The Cambridge, Massachusetts enterprise is issuing 5,454,545 shares priced at $8.25. The company trades on . . . → Read More: Immunotherapy Biotech Raising $45 Million in IPO

Univ. Lab Creates Open-Source Intelligent Assistant

By Alan, on March 11th, 2015%

Developers of the Sirius open-source intelligent personal assistant software, l-r, professors Lingjia Tang and Jason Mars, with graduate students Johann Hauswald and Yiping Kang (Joseph Xu, University of Michigan)

11 March 2015. A computer science lab at University of Michigan is developing an intelligent personal assistant program that responds to voice commands like . . . → Read More: Univ. Lab Creates Open-Source Intelligent Assistant

Trial Shows Current Drug Slows Alzheimer’s Onset

By Alan, on March 11th, 2015%

Michela Gallagher (Johns Hopkins University)

11 March 2015. A clinical trial testing a current drug to treat epilepsy shows the drug can delay development of Alzheimer’s disease in its earliest stages. Results of the study, conducted by researchers at Johns Hopkins University for AgeneBio Inc., two year-old pharmaceutical company in Baltimore, appear online . . . → Read More: Trial Shows Current Drug Slows Alzheimer’s Onset

FDA Approves Antibody for Childhood Nerve Cell Cancer

By Alan, on March 10th, 2015%

Nerve cells in brain illustration (NIH.gov)

10 March 2015. The U.S. Food and Drug Administration approved today dinutuximab, an engineered antibody to treat neuroblastoma, a rare cancer affecting nerve cells in young children. Dinutuximab is developed by United Therapeutics, a biotechnology company in Silver Spring, Maryland and marketed under the brand name Unituxin.

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise